Zacks Research Brokers Decrease Earnings Estimates for PAHC

Phibro Animal Health Co. (NASDAQ:PAHC) – Stock analysts at Zacks Research decreased their Q3 2025 earnings per share estimates for Phibro Animal Health in a research note issued on Wednesday, November 20th. Zacks Research analyst R. Department now expects that the company will post earnings of $0.35 per share for the quarter, down from their prior estimate of $0.37. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.61 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q1 2026 earnings at $0.32 EPS, Q3 2026 earnings at $0.33 EPS and Q1 2027 earnings at $0.48 EPS.

Other equities analysts also recently issued reports about the company. Bank of America upped their target price on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Friday, August 30th. StockNews.com lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday, November 20th. Barclays lifted their target price on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price on the stock. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $16.50.

Phibro Animal Health Trading Down 1.7 %

NASDAQ PAHC opened at $23.73 on Monday. Phibro Animal Health has a 12-month low of $9.49 and a 12-month high of $25.98. The company has a fifty day simple moving average of $23.24 and a two-hundred day simple moving average of $20.12. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The stock has a market cap of $961.14 million, a P/E ratio of 55.19, a P/E/G ratio of 0.61 and a beta of 0.51.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. The company had revenue of $273.16 million for the quarter, compared to the consensus estimate of $262.44 million.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.02%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Insider Buying and Selling at Phibro Animal Health

In other news, Director E Thomas Corcoran bought 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The stock was purchased at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the purchase, the director now directly owns 25,000 shares in the company, valued at approximately $500,500. This trade represents a 25.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 50.07% of the company’s stock.

Institutional Trading of Phibro Animal Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PAHC. CWM LLC raised its position in shares of Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the period. nVerses Capital LLC purchased a new position in shares of Phibro Animal Health in the 3rd quarter valued at about $70,000. Quantbot Technologies LP acquired a new position in Phibro Animal Health in the 3rd quarter worth about $70,000. Summit Securities Group LLC purchased a new position in Phibro Animal Health during the second quarter worth approximately $83,000. Finally, China Universal Asset Management Co. Ltd. boosted its position in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after purchasing an additional 1,522 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.